openPR Logo
Press release

Blood Pressure Monitoring Devices Market to Surpass USD 6 Billion by 2032, Growing at 10.01% CAGR Amid Rising Hypertension Burden and Digital Health Adoption | DelveInsight

04-17-2026 10:58 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Blood Pressure Monitoring Devices Market

Blood Pressure Monitoring Devices Market

Key Companies in the Blood Pressure Monitoring Devices Market are Koninklijke Philips N.V., General Electric Company, A&D Company, Hill-Rom Services Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF HEALTH PRODUCTS INC, Microlife Corporation, Rossmax International Ltd, OMRON Healthcare Inc., SCHILLER AG, Contec, Spengler, ICU Medical Inc., B. Braun Melsungen AG, Biobeat, Aktiia SA, Caretaker LLC, and others.
The global blood pressure monitoring devices market is witnessing a significant transformation, driven by the increasing global burden of hypertension and cardiovascular diseases, rapid technological advancements, and the growing adoption of home healthcare solutions. According to the latest analysis, the market is projected to grow from USD 2,842.32 million in 2024 to USD 6,086.50 million by 2032, expanding at a robust CAGR of 10.01% during the forecast period (2025-2032).

This sustained growth reflects a broader shift in healthcare delivery models, where continuous monitoring, preventive care, and remote patient management are becoming central to improving patient outcomes.

Discover in-depth insights into the rapidly evolving Blood Pressure Monitoring Devices market-access the full report now: https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market [https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Blood Pressure Monitoring Devices Market Overview: Rising Demand for Continuous Blood Pressure Monitoring

Blood pressure monitoring devices are essential tools used to measure and track an individual's blood pressure levels. These devices typically include a cuff, sensor, and display system and are available in manual, digital, and wearable formats. Their role in diagnosing and managing hypertension and related cardiovascular conditions has made them indispensable in both clinical and home-care settings.

The market is expanding rapidly due to the increasing need for early detection and effective management of hypertension-a major risk factor for heart attack, stroke, and kidney failure. As healthcare systems shift toward preventive and value-based care, the demand for accurate, easy-to-use, and connected monitoring devices continues to rise.

Explore key growth drivers, emerging technologies, and leading companies shaping the future of blood pressure monitoring-download the report now: https://www.delveinsight.com/sample-request/blood-pressure-monitoring-devices-market [https://www.delveinsight.com/sample-request/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Key Growth Drivers Fueling Blood Pressure Monitoring Devices Market Expansion

1. Rising Prevalence of Hypertension and Cardiovascular Diseases

The growing global incidence of hypertension is a primary factor driving demand for blood pressure monitoring devices. With an estimated 1.29 billion adults aged 30-79 years affected worldwide, hypertension remains one of the most common chronic conditions globally.

Additionally, cardiovascular diseases continue to rise, with millions of individuals requiring regular monitoring to manage risks and prevent complications. The strong correlation between uncontrolled blood pressure and severe health outcomes is prompting both healthcare providers and patients to adopt continuous monitoring solutions.

2. Increasing Shift Toward Home Healthcare and Remote Monitoring

The healthcare industry is undergoing a major transition toward decentralized care models. Patients are increasingly opting for home-based monitoring solutions that offer convenience, affordability, and continuous tracking without frequent hospital visits.

The rise of remote patient monitoring (RPM) platforms has further accelerated this trend. Connected blood pressure devices now enable real-time data sharing with healthcare providers, facilitating proactive intervention and improved disease management.

3. Technological Advancements Enhancing Device Capabilities

Technological innovation is reshaping the blood pressure monitoring landscape. Modern devices now incorporate features such as:

* AI-powered analytics
* Bluetooth and smartphone connectivity
* Cloud-based data storage
* Wearable and cuffless monitoring technologies

These advancements are improving accuracy, usability, and patient engagement. For instance, AI-integrated devices can detect irregular heart rhythms such as atrial fibrillation, enabling early diagnosis and reducing the risk of severe complications.

4. Increasing Product Development and Innovation

Leading market players are investing heavily in research and development to introduce next-generation devices. Recent innovations include:

* AI-enabled home monitors with real-time diagnostics
* Continuous wearable patches for 24-hour monitoring
* Cuffless blood pressure tracking technologies

Such innovations are not only enhancing patient convenience but also expanding the scope of monitoring beyond traditional clinical environments.

Stay ahead in the digital health revolution with comprehensive market forecasts, trends, and competitive analysis-get your copy today: https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market [https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Blood Pressure Monitoring Devices Market Challenges and Restraints

Despite strong growth prospects, the market faces several challenges:

* Accuracy concerns in consumer-grade devices, which may impact clinical reliability
* Stringent regulatory requirements, leading to longer approval timelines
* High costs of advanced devices, limiting accessibility in developing regions
* User errors in home monitoring, resulting in inconsistent readings

Addressing these challenges through improved device design, patient education, and regulatory streamlining will be critical for sustained market growth.

Blood Pressure Monitoring Devices Segment Analysis: Upper Arm Monitors Lead the Market

Blood Pressure Monitoring Devices Market By Product Type

The digital/automated blood pressure monitors segment dominates the market, with upper arm-based monitors accounting for nearly 60% of the market share in 2024.

This dominance is attributed to:

* Higher accuracy due to proximity to the heart
* Clinical validation by global health organizations
* Strong recommendation by healthcare professionals

These devices are widely considered the gold standard for home monitoring and are increasingly integrated with telehealth platforms for remote patient management.

Blood Pressure Monitoring Devices Market By End-User

The hospital segment holds the largest market share (over 59% in 2024), driven by:

* High patient volume
* Need for continuous monitoring in critical care
* Investment in advanced clinical-grade devices

However, the home healthcare segment is the fastest-growing, supported by:

* Rising chronic disease prevalence
* Increasing adoption of telemedicine
* Growing geriatric population

Unlock strategic insights to capitalize on the USD 6+ billion market opportunity-request a sample report today: https://www.delveinsight.com/sample-request/blood-pressure-monitoring-devices-market [https://www.delveinsight.com/sample-request/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Blood Pressure Monitoring Devices Regional Insights: North America Dominates, Asia-Pacific Emerges as Fastest Growing

North America Blood Pressure Monitoring Devices Market

North America is expected to maintain its leadership position, accounting for approximately 35% of the global market share. Key factors include:

* High prevalence of hypertension
* Advanced healthcare infrastructure
* Strong adoption of digital health technologies
* Presence of major industry players

Additionally, increased healthcare spending and awareness of preventive care continue to strengthen the region's market position.

Europe Blood Pressure Monitoring Devices Market

Europe represents a mature market characterized by:

* Aging population
* High demand for chronic disease management
* Strong regulatory framework ensuring device quality

The region is also witnessing rapid adoption of smart and connected monitoring devices, particularly in countries such as Germany and the UK.

Asia-Pacific Blood Pressure Monitoring Devices Market

Asia-Pacific is poised to be the fastest-growing region, driven by:

* Rapid urbanization and lifestyle changes
* Rising prevalence of hypertension and diabetes
* Expanding healthcare infrastructure
* Increasing government initiatives and awareness programs

Countries like China, India, and Japan are emerging as key growth hubs due to their large patient populations and growing adoption of digital health technologies.

Blood Pressure Monitoring Devices Competitive Landscape: Innovation Driving Market Competition

The blood pressure monitoring devices market is moderately consolidated, with a mix of established players and emerging innovators shaping the competitive landscape.

Leading Blood Pressure Monitoring Devices Companies Include:

* Koninklijke Philips N.V.
* General Electric Company
* A&D Company
* Hill-Rom Services Inc.
* American Diagnostic Corporation
* Withings
* Spacelabs Healthcare
* Braun Healthcare
* Microlife Corporation
* OMRON Healthcare Inc.
* SCHILLER AG
* B. Braun Melsungen AG
* Biobeat
* Aktiia SA
* Caretaker LLC

Established companies dominate the market with clinically validated products and extensive distribution networks. Meanwhile, startups and technology-driven firms are disrupting the market with innovations such as AI-powered analytics, wearable devices, and cuffless monitoring solutions.

Recent Developments in Blood Pressure Monitoring Devices Market

The Blood Pressure Monitoring Devices market has witnessed several notable advancements:

* In September 2025, the FDA cleared Apple's new hypertension detection feature, showcased at its September 9 event with the iPhone Air. Rolling out globally by the end of the month on Apple Watch Series 9, 10, 11, and Ultra 2 and 3, the feature uses the optical heart sensor to monitor blood vessel responses over 30 days and alerts users of potential high blood pressure. If notified, users should track their blood pressure with a cuff for seven days and consult a doctor.
* In January 2025, the FDA cleared Biobeat Technologies Ltd.'s BB-613-BPM Patch, a wearable device that tracks blood pressure changes using Pulse Wave Transit Time (PWTT). This device requires calibration with an FDA-cleared oscillometric monitor and provides 24-hour monitoring with user-initiated measurements every 15 minutes. Data collected can be accessed via the Biobeat platform for healthcare professionals to review.
* In September 2024, Carematix launched the first connected blinded blood pressure monitor and scale designed for clinical trials. This system ensures data integrity while maintaining participant and investigator blinding, supporting trial accuracy, and enabling timely interventions without compromising study protocols.

Identify high-growth segments and innovation trends in remote monitoring and AI-driven healthcare, click here to access the latest analysis: https://www.delveinsight.com/sample-request/blood-pressure-monitoring-devices-market [https://www.delveinsight.com/sample-request/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Emerging Trends Shaping the Blood Pressure Monitoring Devices Market

1. AI and Data-Driven Healthcare

Artificial intelligence is enabling predictive analytics, early detection, and personalized treatment strategies, transforming hypertension management from reactive to proactive care.

2. Growth of Telehealth Ecosystems

Integration with telemedicine platforms is allowing healthcare providers to monitor patients remotely, improving adherence and reducing hospital visits.

3. Rise of Wearable and Cuffless Technologies

Wearable devices and cuffless monitoring solutions are gaining traction, offering greater convenience and continuous tracking capabilities.

4. Increased Focus on Preventive Care

Healthcare systems are increasingly emphasizing early detection and preventive care, driving demand for regular monitoring devices.

Blood Pressure Monitoring Devices Future Outlook: A Transformative Decade Ahead

The blood pressure monitoring devices market is set to undergo a major transformation over the next decade. The convergence of digital health, artificial intelligence, and remote monitoring technologies is expected to redefine patient care models.

With the market projected to exceed USD 6 billion by 2032, companies that focus on innovation, affordability, and integration with digital ecosystems will be best positioned to capitalize on emerging opportunities.

Conclusion

The global blood pressure monitoring devices market is entering a phase of rapid growth and innovation. Driven by the increasing prevalence of hypertension, advancements in technology, and the shift toward home-based care, the market is poised for significant expansion.

As healthcare continues to evolve toward patient-centric and data-driven models, blood pressure monitoring devices will play a crucial role in enabling early diagnosis, improving disease management, and enhancing overall patient outcomes.

About DelveInsight

DelveInsight is a leading market research and consulting firm specializing in life sciences and healthcare intelligence. The company provides actionable insights through comprehensive market reports, helping organizations make informed business decisions in a rapidly evolving healthcare landscape.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=blood-pressure-monitoring-devices-market-to-surpass-usd-6-billion-by-2032-growing-at-1001-cagr-amid-rising-hypertension-burden-and-digital-health-adoption-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blood Pressure Monitoring Devices Market to Surpass USD 6 Billion by 2032, Growing at 10.01% CAGR Amid Rising Hypertension Burden and Digital Health Adoption | DelveInsight here

News-ID: 4477402 • Views:

More Releases from ABNewswire

Primary Biliary Cholangitis Pipeline Set for Major Breakthroughs by 2026 with 25+ Therapies and Strong Clinical Momentum from GlaxoSmithKline, Novartis, and CymaBay Therapeutics | DelveInsight
Primary Biliary Cholangitis Pipeline Set for Major Breakthroughs by 2026 with 25 …
Primary Biliary Cholangitis Companies such as Genfit, Zydus Discovery, Ohara Pharmaceutical, Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Novartis, CymaBay Therapeutics, Calliditas Therapeutics, Hepagene, Calliditas Therapeutics, Dr Falk Pharma, Mirum Pharmaceuticals, GlaxoSmithKline, and others DelveInsight's, "Primary Biliary Cholangitis Pipeline Insight 2026" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Primary Biliary Cholangitis pipeline landscape. It covers the Primary Biliary Cholangitis pipeline drug profiles, including clinical and nonclinical
Asthma market size across the 7MM was estimated at around USD 27 billion in 2024 and is expected to grow at a CAGR of 1.9% by 2036, analyses DelveInsight
Asthma market size across the 7MM was estimated at around USD 27 billion in 2024 …
Asthma Companies are Sanofi, Regeneron Pharmaceuticals, Amgen, AstraZeneca, Areteia Therapeutics, GlaxoSmithKline, Chiesi Farmaceutici, Novartis, Teva Pharmaceuticals, and others DelveInsight's latest Asthma Market Insights, Epidemiology, and Market Forecast - 2036 report provides an in-depth evaluation of current treatment practices, emerging asthma drugs, market share of individual therapies, and forecasted market trends across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The
Overt Hepatic Encephalopathy Market to Witness Steady Growth at a CAGR of 3.59% Through 2034, Driven by Rising Liver Disease Burden and Emerging Therapeutic Innovations | DelveInsight
Overt Hepatic Encephalopathy Market to Witness Steady Growth at a CAGR of 3.59% …
Overt Hepatic Encephalopathy market is poised for sustained growth over the next decade, fueled by increasing prevalence of chronic liver diseases, growing awareness, and advancements in treatment approaches. According to comprehensive market intelligence by DelveInsight, the Overt Hepatic Encephalopathy market size was valued at approximately USD 1,047 million in 2020 across the seven major markets (7MM) and is expected to grow at a CAGR of 3.59% during the forecast period
Osteogenesis Imperfecta Market to Expand Significantly by 2034 with Advancements in Novel Therapies and Rising Disease Awareness, Reports DelveInsight
Osteogenesis Imperfecta Market to Expand Significantly by 2034 with Advancements …
Leading Osteogenesis Imperfecta companies operating in the market include Amgen, UCB, Ultragenyx Pharmaceuticals, Angitia, Sanofi, Mereo BioPharma, among others. The Osteogenesis Imperfecta (OI) market is expected to witness notable growth over the coming years, driven by increasing awareness, advancements in treatment approaches, and ongoing research in rare genetic disorders. According to DelveInsight, the Osteogenesis Imperfecta market size across the 7MM was approximately USD 30 million in 2023 and is projected to

All 5 Releases


More Releases for Blood

Anthony Tony B Powell Releases I Am Drenched in the Blood of Jesus Christ Blood …
Image: https://www.aionewswire.com/storage/images/ckeditor//Author%20Photo_1761680899.jpg A book that shows the true meaning of the blood of Jesus and how it changes lives Blood sustains the body, but it is the blood of Jesus Christ that grants eternal life and salvation to the soul. In his new book, I Am Drenched in the Blood of Jesus Christ: Blood Bought, Blood Stained, Blood Washed [https://www.amazon.com/Am-Drenched-Blood-Jesus-Christ/dp/1662871961], Anthony B. Powell takes readers on a profound spiritual journey into the
Global Blood Processing Consumables(CH 5) Market Size - By Product Type(blood ad …
Market Overview and Report Coverage Blood Processing Consumables encompass various products and materials used in the collection, storage, processing, and transfusion of blood and blood components. This category includes items like blood bags, tubes, filters, and reagents essential for laboratories and hospitals in ensuring safe and effective blood management. The current outlook for the Blood Processing Consumables market indicates robust growth driven by increasing healthcare needs, advancements in medical technology, and a
Medical Blood Bag Market 2027 Global Analysis and Forecasts by Type (Single Bloo …
The medical blood bags are the instruments that are used to store, collect, transport, and transfuse blood and its components. The disposable blood bags replaced the use of glass bottles due to problems associated with the use of glass bottles including insufficient sterility, leading to contamination of the blood, and the development of air bubbles resulted in severe complications during blood transfusion. Access Sample Report@: https://bit.ly/3rGMS4Q Leading Players in the
Global Blood coagulation analyzer Market, Blood coagulation analyzer Market 2020 …
The Blood coagulation analyzer market report provides a comprehensive view of global Blood coagulation analyzer industry. The study provides the industry overview with its growth analysis including CAGR, market shares, sales, gross margin, value, future trends, market opportunities etc. The study also includes analysis of historic data from 2015 to 2019 along with forecast from 2020 to 2025. Further, the Blood coagulation analyzer report contains drivers andrestraints of Blood coagulation
Blood Bank (Blood Banking) Market 2019 Analysis By American Red Cross, Japan Red …
According to this study, over the next five years the Blood Bank (Blood Banking) market will register a 7.7% CAGR in terms of revenue, the global market size will reach US$ 40500 million by 2024, from US$ 26000 million in 2019. Blood Bank (Blood Banking) Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion,
Blood Bank (Blood Banking) Market Stay on The top of this growing business Indus …
Reports Monitor released a new Global Blood Bank (Blood Banking) Market research study with over 100 industry informative desk and Figures spread through Pages and an in-depth TOC on “Blood Bank (Blood Banking) Market”. Global Blood Bank (Blood Banking) market 2019 research lays out the knowledge to achieve positive growth and presents different methods for maximizing your profit. The market study puts forward estimates for Global Blood Bank (Blood Banking) Market 2019 analysis and Forecast